{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:07:33Z","timestamp":1773504453860,"version":"3.50.1"},"reference-count":10,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:p>ABSTRACT The use of eponyms in neurology remains controversial, and important questions have been raised about their appropriateness. Different approaches have been taken, with some eponyms being excluded, others replaced, and new ones being created. An example is Hallervorden-Spatz syndrome, which has been replaced by neurodegeneration with brain iron accuulatium (NBIA). Amiothoplic lateral sclerosys (ALS), for which the eponym is Charcot\u2019s disease, has been replaced in the USA by Lou Gehrig\u2019s disease. Guillain-Barr\u00e9 syndrome (GBS) is an eponym that is still the subject of controversy, and various different names are associated with it. Finally,restless legs syndrome (RLS), which was for years known as Ekbom\u2019s syndrome, has been rechristened as RLS\/Willis-Ekbom syndrome.<\/jats:p>","DOI":"10.1590\/0004-282x20160040","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T15:10:22Z","timestamp":1463238622000},"page":"423-425","source":"Crossref","is-referenced-by-count":2,"title":["What\u2019s in a name? Problems, facts and controversies regarding neurological eponyms"],"prefix":"10.1590","volume":"74","author":[{"given":"H\u00e9lio A. G.","family":"Teive","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pl\u00ednio M. G.","family":"Lima","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco M. B.","family":"Germiniani","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato P.","family":"Munhoz","sequence":"additional","affiliation":[{"name":"University of Toronto,  Canad\u00e1"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1076\/jhin.12.1.91.13779","article-title":"Neurological eponyms: who gets the credit? Essay review","volume":"12","author":"Okun MS","year":"2003","journal-title":"J Hist Neurosci"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.67","article-title":"Whose name is it anyway? Varying patterns of possessive usage in eponymous neurodegenerative diseases","volume":"1","author":"Macaskill MR","year":"2013","journal-title":"PeerJ"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.parkreldis.2008.07.011","article-title":"Professor Karl-Axel Ekbom and restless legs syndrome","volume":"15","author":"Teive HAG","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.sleep.2013.05.016","article-title":"The long-term treatment of restless legs syndrome\/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group","volume":"14","author":"Garcia-Borreguero D","year":"2013","journal-title":"Sleep Med"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14802\/jmd.14034","article-title":"Neurodegeneration with brain iron accumulation: diagnosis and management","volume":"8","author":"Hogarth P","year":"2015","journal-title":"J. Mov Disord"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1177\/0883073812454575","article-title":"The declining use of the Hallervorden-Spatz eponym","volume":"27","author":"Shevell M","year":"2012","journal-title":"J Child Neurol"},{"key":"ref7","series-title":"Neurological eponyms","first-page":"219","volume-title":"The Guillain-Barr\u00e9 syndrome","author":"Wijdicks EF","year":"2000"},{"issue":"5","key":"ref8","first-page":"393","article-title":"\u201cComplications\u201d of the Landry-Guillain-Barr\u00e9-Strohl syndrome","volume":"104","author":"King EG","year":"1971","journal-title":"Can Med Assoc J"},{"key":"ref9","series-title":"Neurological eponyms","first-page":"269","volume-title":"Charcot\u2019s disease: amyotrophic lateral sclerosis","author":"Goetz CG","year":"2000"},{"key":"ref10","series-title":"Lectures on the diseases of the nervous system","first-page":"192","volume-title":"Lecture XIII. On amyotrophic lateral sclerosis. Symptomatology","author":"Charcot JM","year":"1962"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v74n5\/0004-282X-anp-74-05-0423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T13:17:28Z","timestamp":1495545448000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2016000500423&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0004-282X2016000500423"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20160040","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}